MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
- Conditions
- HypertensionDiabetesHyperlipidemiaCardiovascular Disease
- Interventions
- Behavioral: CVRS Intervention
- Registration Number
- NCT02215408
- Lead Sponsor
- Korey Kennelty
- Brief Summary
The study tested whether a pharmacist-run cardiovascular risk service (CVRS) at the University of Iowa can increase use of national standards of care in clinics
- Detailed Description
This project conducted a multicenter, cluster-randomized study utilizing a centralized CVRS for medical offices with large geographic, racial and ethnic diversity to determine the extent to which the CVRS model will be implemented. Twenty primary care offices were randomized to either the CVRS arm or a usual care arm, and 18 continued in the study. Each clinic enrolled 20-30 patients per office for a total of 402 subjects, of which 186 represented racial minorities.
Subjects in the intervention arm clinic had regular contact by phone, email or text with a CVRS clinical pharmacist housed at the University of Iowa. The pharmacist communicated with the subject, with the site clinical pharmacist and, as needed, with the site provider to optimize both the subject's pharmaceutical regimen and lifestyle behaviors. The CVRS intervention lasted for 12 months.
A complex algorithm was used to calculate the degree to which the subject's care and medical regimen follows national guidelines for reducing the risk of developing cardiovascular risk.
Post-intervention telephone interviews are being conducted with 20 intervention subjects in order to assess their experience with the intervention and barriers and facilitators to the intervention.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 402
- English speakers age 55 or greater
- Must have a medical history of at least one of the following:
- Coronary artery disease
- Myocardial infarction
- Stroke
- Transient Ischemic Attack
- Atrial Fibrillation
- Systolic heart failure
- Peripheral vascular disease/claudication
- Carotid artery disease
- Diabetes with either: Low density lipoprotein (LDL) 100 or greater AND/OR systolic blood pressure 140 or higher or diastolic blood pressure 90 or higher
- Signs of acute angina, stroke, heart failure or renal failure
- Systolic blood pressure 200 or greater or diastolic blood pressure 115 or greater
- Significant hepatic disease, including: Cirrhosis, Hepatitis B or C infection, Alanine Aminotransferase (ALT) or Aspartate Aminotransferase (AST) 3 times control or higher, or total bilirubin 2.0 mg/dl or higher
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description CVRS Intervention CVRS Intervention CVRS pharmacist followed the patient for 12 months in order to decrease the patient's risk of developing cardiovascular disease.
- Primary Outcome Measures
Name Time Method The mean percent of applicable Guideline Advantage standards of care that are met at 12 months 12 months Of the 53 specific standards of care listed in the Guideline Advantage criteria, the mean percent of those standards applicable to each subject that are met at the 12 month time point
- Secondary Outcome Measures
Name Time Method The percent of intervention group patients who rate the intervention as helpful (versus not helpful) 24 months Of the subset of 20 intervention group patients who are interviewed about the study intervention, the percent who state that the intervention was helpful (versus not helpful).
The average cost per subject, measured in dollars and cents, of implementing the intervention 12 months The cost per subject will include costs for visits to the primary care physician, the cost of prescribed drugs, and the cost for the time spent by study pharmacists communicating with the patient, creating a care plan, and communicating with the patient's primary care provider.
Trial Locations
- Locations (18)
Genesis Health System
🇺🇸Davenport, Iowa, United States
Idaho State University
🇺🇸Pocatello, Idaho, United States
University of Iowa
🇺🇸Iowa City, Iowa, United States
Northeast Iowa Medical Education Foundation
🇺🇸Waterloo, Iowa, United States
SUNY-University of Buffalo
🇺🇸Buffalo, New York, United States
Texas Tech University Health Science Center
🇺🇸Amarillo, Texas, United States
University of Florida
🇺🇸Gainesville, Florida, United States
University of South Florida
🇺🇸Tampa, Florida, United States
Siouxland Medical Education Foundation
🇺🇸Sioux City, Iowa, United States
University of North Carolina at Chapel Hill
🇺🇸Chapel Hill, North Carolina, United States
University of Texas Health Science Center at San Antonio
🇺🇸San Antonio, Texas, United States
University of Utah
🇺🇸Salt Lake City, Utah, United States
Temple University
🇺🇸Philadelphia, Pennsylvania, United States
University of Wisconsin
🇺🇸Madison, Wisconsin, United States
Wheaton Franciscan Medical Group
🇺🇸Milwaukee, Wisconsin, United States
Milwaukee Health Services,Inc.
🇺🇸Milwaukee, Wisconsin, United States
Memorial Hermann Hospital System
🇺🇸Houston, Texas, United States
Midwestern University
🇺🇸Downers Grove, Illinois, United States